ATP1B3 and hepatocellular carcinoma: Subsequently, 34 chemicals analysis results showed that 10 μM and 100 μM Progesterone slightly reduced ATP1B3 expression in HepaRG cells, indicating that Progesterone may be a combined drug strategy for sorafenib in the treatment of HCC.